• Increase font size
  • Default font size
  • Decrease font size
home | about us | contact us
Search
Search Only:

Search Keyword quantum immunologics

Total: 42 results found.

Marketwire TAMPA, FL--(Marketwire - August 5, 2010) - Quantum Immunologics, Inc. (QI or Company), a privately owned biotech company focused on cancer research,nnounced today that its independent ...
Marketwire TAMPA, FL--(Marketwire - April 20, 2010) -Quantum Immunologics, Inc. (QI or Company), a privately held biotechnology company, announced today that its intelectual patent counsel, Wei-ning ...
... Biotechnology (NASDAQ:GNBT) as a proxy for its wholly-owned immunotherapeutic subsidiary, Antigen Express, and Quantum Immunologics, Inc. a private company. Mentor Capital, Inc. invests in all companies ...
... SCI Corp. (AMEX:CVM) and Generex Biotechnology (NASDAQ:GNBT) as a proxy for its wholly-owned immunotherapeutic subsidiary, Antigen Express, and Quantum Immunologics, Inc. a private company. Mentor ...
... – SCI Corp. (AMEX:CVM) and Generex Biotechnology (NASDAQ:GNBT) as a proxy for its wholly-owned immunotherapeutic subsidiary, Antigen Express, and Quantum Immunologics, Inc. a private company. In addition ...
... immunotherapeutic subsidiary, Antigen Express, and Quantum Immunologics, Inc. a private company. Neurocrine Biosciences, Inc.(Nasdaq: NBIX) saw its shares close the day on heavy volume with a spike of ...
The ProActive News Room website for Quantum Immunologics (QI) has been updated to include a new video interview, a 25-page PDF update report, and a link for more information on QI's upcoming presentation ...
The BioMedReports.com stock research download section has been updated today to reflect my new 22-page PDF report and overview of Mentor Capital (OTC: MNTR.PK), Quantum Immunologics (QI) (privately held), ...
... among the companies it judges to have the best commercial and medical technology development potential. Privately held Quantum Immunologics (QI) will account for the majority of the CI Fund's initial ...
... (90% air) to make them highly permeable for interaction with cells of the immune system. Quantum Immunologics (QI) is a privately held, clinical-stage company that is engaged in the research, development, ...
11. RxNews Recap for Monday 11-09-09
(Home Page/Home Page)
... skin care solutions based on nutritional science, announced today their newest product, PhytoBurst™ Nutritional Chews. Mentor Capital, Inc.'s (OTC:MNTR) major investee, Quantum Immunologics, reported ...
Quantum Immunologics (QI) (privately held) is dedicated to improving the treatment outcome and quality of life for cancer patients through the research, development, and production of innovative therapeutic ...
... (OTCBB) system. The move to the OTCBB was accelerated by the Company’s acquisition of a significant interest in Quantum Immunologics (click on preceding link for QI’s News Room page and more details on ...
14. FDA Calendar Extreme Trades: 85 Single Digit Stocks
(Premium Content/Subscriber Only Content)
... being quoted on the Over-the-Counter Bulletin Board (OTCBB) system. The move to the OTCBB was accelerated by the Company’s acquisition of a significant interest in Quantum Immunologics (click on preceding ...
... were uploaded for privately-held Quantum Immunologics (QI) related to its experimental dendritic cell (DC) cancer immunotherapy (CI) that targets OFA-iLRP (oncofetal antigen – immature laminin receptor ...
... investee Quantum Immunologics, Inc.   The stock research section of BioMedReports.com has been expanded to include medical, scientific, and industry research report categories – including five new ...
The stock research section of BioMedReports.com has been expanded to include medical, scientific, and industry research report categories – including five new files for privately-held Quantum Immunologics ...
... (public-traded proxy for Quantum Immunologics), Dendreon (NASDAQ:DNDN), ImmunoCellular Therapeutics, Antigenics (NASDAQ:AGEN), Biovest (BVTI.PK), Celldex TherapeuticsOncothyreon (NASDAQ:ONTY), Northwest ...
... (CI) Index, which has posted a gain of about 57% since its inception seven weeks ago. The equal-weight CI Index tracks the following stocks: Mentor Capital (MNTR.PK) (public-traded proxy for Quantum Immunologics), ...
... view the Mentor Capital Cancer Immunotherapy Index of 10 stocks.   1.) Blockbuster, billion dollar sales potential for QI's experimental cancer immunotherapy 2.) Quantum Immunologics (QI) ...
... for Quantum Immunologics, Inc., a private company in FDA breast cancer trials. Oncothyreon (NASDAQ:ONTY - News), with significant lung cancer involvement, followed in CI Index performance with a 71% gain ...
... weeks ago. The equal-weight CI Index tracks the following stocks: Mentor Capital (MNTR.PK) (as a public-traded proxy for tracking Quantum Immunologics), Dendreon (NASDAQ:DNDN), ImmunoCellular Therapeutics, ...
... Quantum Immunologics, Inc. (QI). QI is a privately held company with a goal of initially marketing its active immunotherapy for the treatment of breast cancer in the U.S., in addition to planning for ...
... in the first of four steps leading to an anticipated merger and name change, Mentor Capital (MNTR.PK) acquired a 20% ownership stake in clinical stage cancer immunotherapy company, Quantum Immunologics, ...
SAN DIEGO--Mentor Capital, Inc. (Pink Sheets:MNTR) announces that Quantum Immunologics, Inc. (QI) has met a significant milestone marking the beginning of its FDA-authorized breast cancer ...
...  immunotherapeutic subsidiary, Antigen Express, and Quantum Immunologics, Inc. a private company. In cancer immunotherapy the patient's own immune system is trained to identify and attack cancer cells ...
... subsidiary, Antigen Express, and Quantum Immunologics, Inc. a private company. In cancer immunotherapy the patient's own immune system is trained to identify and attack cancer cells as the body normally ...
...  immunotherapeutic subsidiary, Antigen Express, and Quantum Immunologics, Inc. a private company. In cancer immunotherapy the patient's own immune system is trained to identify and attack cancer cells ...
... (AMEX:CVM) and Generex Biotechnology (NASDAQ:GNBT) as a proxy for its wholly-owned immunotherapeutic subsidiary, Antigen Express, and Quantum Immunologics, Inc., a private company. Overall, the combined ...
... DataTrak International, Quantum Immunologics, with Protox Therapeutic's presentation pending. DataTrak International, Inc. is presenting on Wednesday, January 13, 2010 at 9:45 AM. Mike Havrilla reports: ...
... already significant immunotherapy investment interest in CI Index member Quantum Immunologics, Inc., a private company in FDA authorized breast cancer trials. Other Cancer Immunotherapy Index companies ...
... Group (BB), PaxVax (Private), Peregrine Pharmaceuticals (Nasdaq), Pico-Tesla Magnetic Therapies (Private), PolyRemedy (Private), Pressure BioSciences, (Nasdaq), QuantRx Biomedical (BB), Quantum Immunologics ...
SAN DIEGO--(BUSINESS WIRE)--Mentor Capital, Inc. (Pink Sheets:MNTR) from the onset selected to invest in one cancer company, Quantum Immunologics, whose immunotherapy, in Mentor's independent medcal ...
TAMPA, FL--Quantum Immunologics, Inc. (QI), a privately held biotechnology company, announced today that it has entered into a Collaboration Agreement with Auburn University to bring its novel cancer ...
... BioSciences, (Nasdaq), QuantRx Biomedical (OTCBB), Quantum Immunologics (Private), Quintessence Biosciences (Private), Safeguard Scientifics (NYSE), ScyFIX (Private), Senesco Technologies (AMEX), Spherix ...
SAN DIEGO--(BUSINESS WIRE)--Mentor Capital, Inc.'s (Pink Sheets:MNTR) major investee, Quantum Immunologics, reported significant advances in its recent Quarterly Conference Call. Mentor Capital vlue ...
SAN DIEGO--Mentor Capital, Inc.'s (Pink Sheets:MNTR) major investee, Quantum Immunologics, reported significant advances in its recent Quarterly Conference Call. Mentor Capital value closely ...
...  patients as compared to the severe side effects experienced after chemotherapy, radiation, or surgical treatments. Mentor Capital’s primary investee, Quantum Immunologics, Inc., is conducting ...
... Antigen Express. The Mentor Capital, Inc. value substantially tracks the value of its major investee, Quantum Immunologics, Inc., which is private. In the cancer immunotherapy field, the goal is to ...
... being quoted on the Over-the-Counter Bulletin Board system.   The move to the OTCBB was accelerated by the July 8, 2009 acquisition of a significant interest in Quantum Immunologics, Inc., a leading ...
TAMPA, FL--Quantum Immunologics, Inc. (QI), a privately owned biotech company announced today that it is scheduled to present at the Rodman & Renshaw 11th Annual Healthcare Conference on Friday, September ...
... improvement of Mentor Capital, Inc. (Pink Sheets: MNTR). On July 10, 2009, Mentor Capital announced it had acquired a significant interest in and was a new public market proxy for Quantum Immunologics, ...

Get Free Email and Phone News Alerts

* Your email address:
* Preferred Format:
* Enter the security code shown:
 
Home | Privacy Policy
© 2010 BioMedReports.com. All rights reserved